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REVIEW
Electrical muscle stimulation 
in thomboprophylaxis: review and a derived 




Introduction: Electrical muscle stimulation (EMS) is an FDA-approved thromboprophylactic method. Thrombus 
pathogenesis is considered to depend on factors related to components of the vessel wall, the velocity of blood, and 
blood consistency—collectively known as, the Virchow’s triad.
Objective: The testimony supporting the thromboprophylactic effects of the EMS is reviewed. An emphasis is placed 
on the fact that, EMS has demonstrated, in certain circumstances, an efficacy rate that cannot be fully explained 
by the Virchow’s triad; also that, in reviewing relevant evidence and the theorized pathophysiological mechanisms, 
several findings collectively point to a potentially missed point. Remarkably, venous thromboembolic disease (VTE) 
is extremely more common in the lower versus the upper extremities even when the blood velocities equalize; EMS 
had synergistic effects with intermittent compressive devices, despite their presumed identical mechanism of action; 
sleep is not thrombogenic; non-peroperative EMS is meaningful only if applied ≥5 times daily; neural insult increases 
VTEs more than the degree expected by the hypomobility-related blood stasis; etc. These phenomena infer the pres-
ence of a 4th thrombogenetic factor: neural supply to the veins provides direct antithrombic effects, by inducing 
periodic vessel diameter changes and/or by neuro-humoral, chemically acting factors. EMS may stimulate or substi-
tute the 4th factor. This evidence-based hypothesis is analyzed.
Conclusion: A novel pathophysiologic mechanism of thrombogenesis is supported; and, based on this, the role of 
EMS in thromboprophylaxis is expanded. Exploration of this mechanism may provide new targets for intervention.
Keywords: Electrical muscle stimulation, NMES, Thrombosis, DVT, VTE, Nervous system, Endothelium, Vasomotion, 
Pathophysiology, Thrombogenesis
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According to Virchow’s classical triad (Virchow 1856), 
thrombus pathogenesis depends on factors related to 
components of the vessel wall (endothelial injury or 
dysfunction); of the velocity of blood flow (stasis/turbu-
lence); and of the blood consistency (hypercoagulability). 
Venous thromboembolic disease (VTE), consequential 
to pathologic thrombus formation, is regarded to result 
from one or, more frequently, more abnormalities related 
to these factors; and remains one of the main preventable 
causes of death (Heit 2015). In-hospital cases account for 
about three-fourth of the VTE-related fatalities (Cohen 
et al. 2007).
Electrical muscle stimulation (EMS), the application of 
electrical current usually through superficial (skin) elec-
trodes placed over the main muscle groups of the lower 
extremities, inducing repeated muscle contractions, 
is an FDA-approved method for postoperative VTE 
prophylaxis. For over half a century, its antithrombic 
effect has been attributed to acceleration of the venous 
blood flow of the lower extremities as a consequence of 
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muscle contractions causing compression of the veins; 
and results in an increase in preload, hence, cardiac 
output (Doran et  al. 1964). This acceleration effect was 
demonstrated in numerous studies; for instance, in an 
open-label intra-subject study, peroneal nerve EMS (with 
pulses of 1 Hz, and a maximum charge of 0.02 mC/pulse) 
in healthy volunteers caused an increase in peak blood 
velocities in the peroneal, posterior tibial and gastroc-
nemius veins by 216, 112 and 137 %, respectively (Griffin 
et al. 2016).
Hence it is corroborated that, EMS applied on the 
lower extremities causing brisk muscle contractions 
during operations remarkably reduces the early post-
operative VTE rate. It has been shown that, most VTEs 
diagnosed during the 1st postoperative week actually 
occur during the operation time, a fact suggesting that, 
EMS might always need to be considered during major 
operations, a time period during which the blood flow 
is greatly reduced in the lower extremities (Maynard 
et al. 1991). In accordance, a randomized controlled trial 
(RCT) that compared EMS (10 Hz, 100 V) plus standard 
care with standard care alone in 90 patients undergo-
ing total knee arthroplasty, validated this effect, with 11 
versus 31 % VTE rate respectively, p = 0.02 (Izumi et al. 
2014). In another RCT, peroperative EMS (50 ms, 8 Hz, 
40–50 mA) was compared with and found to be superior 
to dextran 40: the incidence of asymptomatic VTE in the 
dextran versus the EMS group was, 30 versus 14 % (mar-
ginal superiority of the EMS, as 95 % CI 0.90–1.16), and 
that of silent pulmonary emboli was 35 vs. 10 % (95 % CI 
0.11–0.97), respectively (Lindström et  al. 1982). Like-
wise, a third RCT of EMS applied during the operation 
caused postoperative VTE rate reduction from 10 to 3 % 
(p < 0.05) (Doran and White 1967); while a fourth RCT in 
a similar context had two cases of VTE in the EMS versus 
six in the control branch, reaching no statistical signifi-
cance (p = 0.28) apparently because it included a highly 
selected population with low incidence of VTE, and also, 
the EMS energy delivered had been very low (15–25 V) 
(Goyal et  al. 2012). In the same lines, in a prospective 
study, calf EMS (30 ms, 15–45 V) during general opera-
tion applied to one of the two extremities led to 8 % of 
VTE occurrence versus 21 % in the opposite (non-stim-
ulated) site, a significant reduction (OR 0.33; 95  % CI 
0.15–0.77) (Browse and Negus 1970).
Perhaps the most compelling argument supporting the 
aforementioned conception of the mechanism of action 
of the EMS is that, thrombi form almost exclusively in 
the lower extremity vasculature, a fact about which cur-
rent literature (own review) does not provide sufficient 
explanatory evidence of any other difference from that 
of any other body area further to the slowness of blood 
flow in them—which the EMS counteracts—, a fact 
presumably related to gravity, but also to their anatomy, 
innervation, or even, to a degree, to the relation to the 
heart (Flinterman et al. 2008; Wright et al. 1951). Indeed, 
only about 4 % of the VTEs occur in the upper extremi-
ties (Muñoz et al. 2008), as noted in a vast postoperative 
cohort, in which actually most upper extremity VTEs 
were caused by catheters or local pressure of the veins, 
mainly from a neoplasm (Flinterman et al. 2008). In par-
allel to that, the sluggishness of lower extremity blood 
velocity has been verified, and in the supine horizontal 
position, that was found to be about half of the one of the 
upper extremity (Wright et al. 1951).
However, if blood velocity had been the only explana-
tion to all these phenomena, thrombus incidence in the 
upper would have become equal, or at least somewhat 
similar, to that of the lower extremities, once blood 
velocities equalize in all extremities, an occurrence fea-
sibly achieved by lower extremity elevation by 10°–15° 
while in the supine position, as shown in postoperative 
patients (Wright and Osborn 1952); or with EMS appli-
cation, which increases velocities even further—and 
even more efficiently than the intermittent compressive 
devices (ICDs, see below) (Broderick et  al. 2014). Yet 
in that position of 15° in the operating room, the ratio 
of postoperative VTE rate of the lower over that of the 
upper extremities was, again, very high. In a RCT (with 
N = 200 patients) in that setting, no thrombi developed 
postoperatively in the upper extremities versus 12 devel-
oped in the elevated lower extremities (a statistically sig-
nificant difference); versus 7 in the non-elevated lower 
extremities of a third group of the study that had EMS 
(0.5  Hz, 120  V) applied on them, during the operation. 
Hence, neither lower extremity elevation nor EMS appli-
cation during the operation had been effective enough 
to reduce the lower extremities’ VTE rate to the (zero, 
in that study) level of the upper extremities’. Further-
more, despite the fact that the study was not empowered 
adequately to detect the difference between EMS versus 
elevation, the statistically insignificant (p  =  0.25) dif-
ference of 12 versus 7 cases of VTE favoring the EMS 
group may still be an interesting observation, suggest-
ing that, perhaps, velocity is not the only mechanism of 
the EMS-induced thromboprophylactic action (Wright 
and Osborn 1952; Doran et al. 1970). The fact that EMS 
accelerates blood flow more efficiently than the leg eleva-
tion is unlikely to be the explanation of this observation, 
as will be discussed below (Morris and Woodcock 2004). 
More importantly, additional RCTs attested that, when 
mechanical measures are applied on the lower extremi-
ties (e.g. during operations), effectively eliminating the 
pathogenetic factor of blood velocity favoring lower over 
upper extremity VTE, lower extremity does not merely 
approximate the upper extremity VTE rate—the latter 
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being extremely low in several postoperative series, espe-
cially if no local factors like central lines provoke upper 
extremity VTE (Browse and Negus 1970; Muñoz et  al. 
2008; Koo et al. 2014; Mokri et al. 2013).
As noted above, the time during the operation has 
been blamed for the occurrence of the early postopera-
tive peak of VTEs. A second lower extremity blood veloc-
ity nadir has been described by Illingworth et al., which, 
according to old studies, occurs on (postoperative) day 
12, on average. Another paradox appearing here is that, 
the 2nd peak of pulmonary emboli was observed on day 
9, i.e., 3 days earlier to the velocity nadir, under the con-
ditions of those observations (Illingworth and Dick 1949) 
(notably, postoperative VTE peak in newer series was 
reported at different timing, but no concurrent blood 
velocity recordings are available for reference) (Muñoz 
et al. 2008).
Accumulating evidence supports the appraisal that 
EMS may also have systemic antithrombic effects, i.e., 
extending beyond the stimulated extremity. A trend 
towards statistical significance (p = 0.10 in an underpow-
ered sample for that particular outcome) for VTE reduc-
tion in the contralateral to the stimulated extremity was 
noted in a prospective study of intraoperatively applied 
EMS (50  ms, 0.2  Hz, in which a relative risk reduction 
of 92 % of the stimulated site was observed, p = 0.0003) 
(Nicolaides et  al. 1972). In some relevance to that, a 
research team concluded that, electrospasmotherapy 
(ECT) that causes contractions has systemic antithrom-
bic effects, as those were observed only in patients not 
on muscle relaxants (Worowski et al. 1970). Yet another 
similar study where muscle relaxants had been admin-
istered and the ECT-induced catecholaminergic surge 
was diminished, circulating plasminogen activator (a fac-
tor with antithrombic effect) was found to be elevated 
after the ECT (Pina and Rodrigues 1974). This eleva-
tion is noted after exercise as well (Cohen et  al. 1968). 
It remains unclear if and to what degree there is a true 
systemic antithrombic effect with EMS, and if that is a 
consequence of electrical stimulation, the resulting mus-
cle contraction, and or associated catecholamine (Cash 
and Garder 1972) or blood flow changes (Broderick et al. 
2010). Then, an interventional study in chronic spinal 
cord injury (SCI) patients submitted to lower extrem-
ity functional EMS (0.35  ms, 30  Hz, 0–132  mA) found 
acute raises of antithrombin and cAMP and decreases 
of thrombin and of ADP-induced platelet aggregation, 
inducing antithrombic effects; as well as raises of the 
factors V and X, known to have either anticoagulant or 
precoagulant role (Sinha et  al. 1977; Kahn et  al. 2010). 
In regards to the impact of blood flow per se on antico-
agulation, intermittent compressive devices (ICDs) [with 
an efficacy of a 60 % postoperative VTE reduction in one 
review that included 15 studies (Urbankova et al. 2006), 
and equivalent efficacy to peroperative anticoagulant 
prophylaxis in another review of 14RCTs plus 3 observa-
tional studies in which RR was 1.4, 95  % C.I. 0.73–2.64 
(Pavon et  al. 2016)] which accelerate flow by external 
vessel compression but cause no muscle contractions, 
were shown to reduce plasminogen activator inhibitor-1 
(Comerota et  al. 1997) and to activate fibrinolysis, with 
no impact on platelets or coagulation factors (Kohro 
et  al. 2005). It remains unproven that EMS is superior 
to ICDs in VTE prophylaxis, as head-to-head studies for 
the clinical outcome of VTE are lacking. It is understood 
that, as EMS stimulates the entire muscle uniformly 
rather than compressing the vessels from outside, the 
peripheral to maximal pressure point blood stasis (i.e., in 
the direction towards the feet) in veins may be avoided 
with the EMS, as opposed to ICDs. However, those short 
interruptions of flow were not shown to cause thrombi. 
Indeed, as discussed below, there is evidence that venous 
stasis becomes significantly thrombogenic when it lasts 
for hours, not seconds. Another theory of this EMS [e.g. 
0.35  ms, 36  Hz; or 0.07–0.56  ms, 1  Hz, in two studies 
(Broderick et al. 2014; Jawad et al. 2014)] possible supe-
riority could be that, it accelerates flow more efficiently 
than ICDs. However, a systematic review of the years 
1970–2002 of all mechanical non electrical thrombopro-
phylactic measures reported that, peak velocity does not 
affect efficacy (Morris and Woodcock 2004). Despite the 
fact that EMS had not been included in the review, it can 
be extrapolated that, relying on hemodynamic param-
eter modifications induced by mechanical measures and 
coming to conclusions about their relative efficacy is not 
appropriate. Finally, combining ICDs with EMS led to 
synergic VTE prophylactic effect, a fact that would not be 
expected should both methods acted by the same mecha-
nism and only, i.e., by flow acceleration (Kopetzky 1994). 
Concluding this paragraph, some evidence suggests that 
EMS may have systemic antithrombic effect; may theo-
retically be superior to ICDs; and its mechanism of action 
may not solely be related to hemodynamic alterations.
A study in neurosurgical patients in which peroperative 
EMS (50 ms, 8 Hz, 40–50 mA) was followed by postop-
erative dextran infusions every 48 h, this (dextran + EMS 
study group) approach led to more VTE reductions when 
the spinal cord rather than the brain had been the dis-
eased site of the nervous system (Boström et  al. 1986). 
Further to this point, it has been observed that, injury of 
the spine in major trauma patients acutely raises VTE rate 
by 20 %; yet when the spinal cord is also injured, repre-
senting a risk factor of 8.6, the likelihood of VTE devel-
opment was >80  %, in a large trauma cohort of average 
incidence of VTE of 58 % (Geerts et al. 1994). Deceptively, 
VTE incidence may be >50 % in SCI patients, with reports 
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varying between 19 and 100 % (Teasell et al. 2009), being 
much higher than that expected from flow deceleration 
alone. Let here point out that, sleep as a cause of hypomo-
bility, yet not disturbing peripheral nerve function, is not 
a known cause of VTE (Heit 2015). Overall, it appears that 
EMS has more to offer in conditions of complete absence 
of neural supply to the lower extremities; and that the lat-
ter, when occurs, greatly increases the VTE rate (Boström 
et al. 1986; Nicolaides et al. 2013).
EMS (3  ms, 1.75  Hz, 0–120  V) applied after multiple 
trauma twice daily was ineffective in VTE prevention (Vel-
mahos et  al. 2005); but when applied at least five times 
daily (Lobastov et al. 2013) (in 20 min sessions, 0.03–2 Hz, 
in high risk patients, with the FDA-approved device Veino-
plus (Griffin et al. 2010), in addition to standard prophy-
laxis), VTE rate was reduced from 25 to 2.5 % (p = 0.007) 
(Lobastov et al. 2014). In the same lines, an RCT in severe 
acute SCI patients found a very remarkable decrease of 
VTE incidence by adding lower extremity EMS (0.05 ms, 
10 Hz) applied 23 h daily to prophylactic dose of unfrac-
tionated heparin (UH) (1 in 15 patients in the EMS + UH 
vs. 8 in 16 patients in the UH group, p  <  0.05), applied 
<2 week after injury for 4 weeks (Merli et al. 1988).
Vasomotor phenomena were observed or increased by 
the EMS (0.2 ms, 1–5 Hz, 1–40 mA) beyond the degree 
expected by mechanical compression and metabolism 
augmentation alone (Tucker et al. 2010). At this juncture 
let us also recall an important FDA-approved EMS indi-
cation, i.e., in pressure ulcer prevention, where it appears 
to interfere with local tissue reactions, such as, increas-
ing local oxygenation, perfusion, and or to exert anti-
infectious effects (Polak et al. 2014). The EMS potentiates 
galvanic sensing of local healing cells and their reaction 
to transepithelial potential elimination of the wounded 
epithelium (Kawasaki et al. 2014). The effects of the EMS 
(0.07–0.56 ms, 1 Hz, 27 mA) on the microcirculation of 
the stimulated extremity, to a degree more pronounced 
than that caused by ICD, were also demonstrated in a 
RCT that utilized laser Doppler fluximetry (Williams et al. 
2014). Another study of the acute effects of EMS in ICU 
patients demonstrated an increase of endothelial reactiv-
ity and a decrease of the vascular reserve, as evaluated 
by near infrared spectroscopy (NIRS), signifying local 
and systemic effects on skeletal muscle microcirculation 
(Angelopoulos et al. 2013). Vasomotor systemic phenom-
ena were shown in other studies as well (Jawad 2012).
In summary
EMS, like any mechanical measure, accelerates blood 
flow and this appears to mediate its thromboprophylactic 
effect, which has been demonstrated, particularly when 
applied peroperatively, in several studies. Indeed, the high 
VTE rate in the lower extremities in comparison to other 
body areas appears to relate to their slow venous circula-
tion, which the EMS counteracts. However, as reflected 
on evidence (and occasionally on critiques, since the 40s) 
(Doran et  al. 1964; Illingworth and Dick 1949) this as a 
standalone explanation does not suffice to illuminate a 
considerable percentage of findings of related studies to 
date. For instance, when all extremities’ venous blood 
flow becomes equal, VTE rates remain quite dissimilar 
between the upper and lower extremities (Doran et  al. 
1970); and when EMS had been used to make venous 
blood velocities between extremities equal, the VTE 
reduction in the lower extremities was likely more pro-
nounced than the reduction that had been achieved by a 
different method (underpowered study, statistical trend 
reached, and clinically notable). Then, despite veloc-
ity manipulations, never has the VTE rate of the lower 
extremities approached the approximately 22-fold lesser 
(Muñoz et al. 2008) levels of that of the upper (Howie et al. 
2005). Postoperative pulmonary emboli incidence timing 
pattern did not match that of blood velocity. EMS prophy-
lactic efficacy may extend to the non-stimulated extremity 
(Nicolaides et  al. 1972; Broderick et  al. 2010); further-
more, EMS appears to exert systemic effects. EMS may be 
superior to ICDs in VTE prophylaxis, yet clinical evidence 
is limited; but the two methods applied together had syn-
ergistic antithrombic effects, making the perception that 
their mechanism of action is identical poorly acceptable 
(Kopetzky 1994). In acute injury/insult of neural supply 
to the lower extremities, VTE rate increases dramatically 
beyond that expected from flow deceleration alone—such 
as in cases of paralysis not involving the nerves, or dur-
ing physiologic sleep. EMS has a lasting post-sessional 
effect that makes it a meaningful intervention if applied 
≥5 times daily (Velmahos et al. 2005; Lobastov et al. 2013; 
Griffin et  al. 2010) or continuously (Merli et  al. 1988) 
[with the remarkable exception of EMS during the opera-
tion (Izumi et al. 2014; Lindström et al. 1982; Doran and 
White 1967; Goyal et al. 2012; Browse and Negus 1970), 
as most early VTEs occur during that period (Maynard 
et al. 1991)]. EMS may interact with perivascular or tissue 
factors or vasomotor processes (Tucker et al. 2010; Polak 
et al. 2014; Kawasaki et al. 2014). Overall, its mechanism 
of action does not seem to be limited to hemodynamic 
modifications. These facts raise the possibility that neural 
factor is of immense importance in thrombus pathogen-
esis (Schneck 2014). All pieces put together may lead to a 
possible conclusion, a hypothesis presented below.
A hypothesis
Neural supply to the veins provides direct antithrombic 
effects
This would constitute a 4th factor in thrombus patho-
genesis (i.e., one beyond Virchow’s triad). Periodic neural 
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activity may cause variations in venous diameter AND/
OR influence the veins by transmitters that induce local 
interactions, resulting in antithrombic mechanical and/
or chemical (neuro-humoral) effects. Presence of a neu-
rogenic pacemaker in vasomotion is likely. The neural 
cells involved may recite in or relate to the sympathetic 
neural system (SNS) or function, or other non-noradr-
energic (see discussion section) neurons, which interact 
with vascular wall components. Furthermore, muscle 
contractility can relate to corelease of endocrinologically 
and immunologically (myokines) active factors (Raschke 
et al. 2013; Pedersen and Febbraio 2008). A biologic role 
in thomboprophylaxis of the latter is possible as well. Any 
or combination of these mechanisms may be involved in 
the functions of the 4th factor.
A direct or indirect insult to this process or a decline 
of its periodic output (which can even be an adaptation 
to the patient’s condition) is expected to increase throm-
bogenicity; also to cause blood stasis, that further wors-
ens the precoagulant state. This concept differs from the 
current view of the vascular wall as a static structure in 
thrombogenesis; but rather, wall motion, perpendicu-
lar to the blood flow, mechanically fragments a primary 
thrombus that begins to form; and/or vascular wall fac-
tors being released in response to neurotransmitters, by 
diffusion reach an adjacent developing thrombus causing 
chemical destabilization.
EMS may stimulate or substitute the 4th factor
This could be an efferent effect through neurons transfer-
ring the pulses to the periphery, or have an initial afferent 
path to the CNS, followed by reflex responses. Let cite, 
EMS is shown to have central effects, which cause central 
neural adaptations. EMS pulses diffuse within the CNS; 
and part of the stimulation returns to the periphery, 
as described/evidenced in Hortobagyi and Maffiuletti 
model (Hortobagyi and Maffiuletti 2011).
As its mechanism of action is not limited to hemody-
namic modifications, EMS may be combined with other 
mechanical measures with synergistic effect (Kopetzky 
1994).
A primary thrombus requires several hours to stabilize 
(chemically and mechanically) (Schulz et  al. 2013). This 
might be the explanation of the fact that, EMS applied 
less frequently than 5 times daily is clinically ineffec-
tive (with time gaps sufficient for thrombus formation). 
Intraoperatively applied EMS is an exception, as most 
VTEs occur during surgery; hence, one single session 
may suffice to substantially reduce the early VTEs. Some 
percentage of prevention of thrombus formation and or 
related thrombolytic cascade activation might explain the 
coagulation factor changes induced by the EMS in the 
aforementioned studies. Another explanation to those 
findings could be a direct effect from the EMS, which, 
as a substitute to the 4th factor, might have induced 
vessel wall release of factors contributing to systemic 
antithrombic effects. A third possibility could be through 
the release of myokines.
The likelihood that the processes of the 4th factor are 
not affected during sleep could explain why sleep, con-
trary to general anesthesia or nerve injury-related immo-
bility, is not thrombogenic.
During the 2nd postoperative week, two contributing 
thrombogenic processes could have evolved under the 
conditions described by Illingworth et al., i.e., a progres-
sive decline of the thrombogenicity due to the recovery 
of the 4th factor and a “reversed-U-shaped” (over time, 
i.e., peak) thrombogenic process due to the slow recovery 
of the (U-shaped, i.e., nadir) blood velocity, ended up in 
a cumulative thrombogenicity peak on day 9 rather than 
day 12 (assuming that the inflammation induced from 
surgery does not contribute remarkably to thrombogen-
esis during that period—at least to a degree different 
between day 9 and day 12) (Fig. 1). 
This (presently described) mechanism is not the only 
one through which EMS exerts VTE thomboprophylaxis. 
Like exercise, it accelerates venous flow (by vessel com-
pression, heart rate acceleration, increase of preload, of 
metabolism etc.), it may cause systemic release of anti-
coagulants or and anti-inflammatory mediators etc. 
(pleotropic effects of EMS/exercise) (Raschke et al. 2013; 
Petersen and Pedersen 2005).
It is possible that there is a difference between inner-
vation—which correlates to the 4th factor component—
of the vessels of the upper extremities versus the lower 
extremities. Experiments in mice have demonstrated 
that, gravity may be causing long-standing neural adapta-
tions, functional and anatomical, at the nerves of the ves-
sels of the extremities; and these will differ in the upper 
from the lower extremities (Monos et  al. 2001). This 
would partly explain the difference in VTE rate among 
the two, which cannot be explained solely with hemo-
dynamic terms; but the addition of the 4th (neurogenic) 
factor may provide an answer.
As with any hypothesis, it requires further research. 
The anatomical representation and detailed functionality 
of the 4th factor need to be explored. Importantly, these 
need to be looked for in a system characterized by peri-
odic activity, such as, the sympathetic neural system and 
its interconnections with the vascular neural plexus (see 
“Discussion” below).
Discussion
Some basic pathophysiology in regards to the interac-
tions involving perivascular neurons, vasomotion and the 
endothelium in hemostasis is cited, and may need to be 
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considered in hypothesizing the potential functionality of 
the 4th factor.
Communication between neurons of the vascular 
wall neural plexus is mediated by adrenergic, choliner-
gic, purinergic (e.g. ATP), peptidergic, and nitrergic (of 
nitric oxide, NO) neurotransmitters (Westcott and Segal 
2013). The perivascular nerves, after calcium influx in 
them, release transmitters that by diffusion or hetero-
cellular communication—mainly via gap junctions—
reach adjacent neural, endothelial and smooth muscle 
cells (SMC). Efferent vasoconstrictive sympathetic fib-
ers, tonically activated, predominate in the plexus. 
Noradrenaline, the main neurotransmitter, causes con-
traction of the SMC via the inositol triphosphate/cal-
cium pathway; while the same molecules may diffuse 
to endothelial cells, causing reactions like NO release, 
which then diffuses to the SMC moderating their pre-
ceded contraction (Kansui et  al. 2008). During sympa-
thetic neural system (SNS) stimulation, other molecules 
may be coreleased, such as, ATP (acting on the endothe-
lium) (Burnstock 2014) and neuropeptide Y (Hirsch and 
Zukowska 2012). The non-noradrenergic systems appear 
to have weak, modulatory role. Sensory fibers, also capa-
ble for efferent transmission after noxious or mechanical 
stimuli, generally induce vasodilatation, via substance 
P, calcitonin-gene-related-peptide-alpha, which acts via 
the G-protein/cAMP pathway, and other neurotransmit-
ters (Donoso et al. 2012).
Vasomotion, best studied in arteries, is the periodic 
spontaneous change in vascular diameter, thus regulating 
local tissue perfusion, blood pressure and other essential 
functions. It is synchronous among remote SMC, causing 
the entire vascular wall to oscillate. Evidence supports 
that it initiates with intermittent asynchronous sarcoplas-
mic reticulum release of calcium, thus activating a cell 
membrane potential/ion current by involving either ino-
sitol triphosphate or ryanodine receptors. Vasomotion 
occurs when the two current events synchronize. Adja-
cent cell coupling via gap junctions or indirect coupling 
appears essential in achieving synchrony of intracellular 
oscillations of calcium influx. The authors of the theory 
suggest that, the pacemaker of the vascular wall can be 
envisaged as a diffuse array of individual cytosolic oscil-
lators that become entrained by a reciprocal interaction 
with the cell membrane (Peng et al. 2001; Koenigsberger 
et  al. 2004). A (cGMP-dependent calcium-activated) 
chloride current may be involved in synchrony between 
SMC in some vessels (Matchkov 2010), while in oth-
ers, with high level of coupling between SMC, endothe-
lial, and SMC with endothelial cells, voltage-dependent 
calcium channels are also involved, and generation of a 
depolarizing current occurs (Nilsson and Aalkjaer 2003). 
Alternatively, a vasoconstrictor-like noradrenaline—may 
induce tonic synchronous depolarization. The role of the 
endothelium in synchronization may depend on whether 
myoendothelial gap junctions are abundant; if so, it 
Fig. 1 Factors contributing to thrombogenecity after general surgery [thrombogenecity vs. time (days)]
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coordinates the electrical responses between neighbor-
ing SMC; if not, it interacts through the release of vaso-
dilators affecting the SMC (Haddock and Hill 2005). In 
comparison to the arteries, most veins contain more adr-
energic terminals, distributed in the media (Birch et  al. 
2008) and their responses to sympathetic stimulation 
is brisker (Racchi et al. 1997) causing reduction in their 
capacitance (Fallick et al. 2011).
Endothelium in hemostasis under non-traumatic con-
ditions releases NO, prostacyclin and adenosine, which 
cause vasodilation, and cAMP and cGMP release from 
the platelets, which inhibit their activation. The venous 
wall releases plasminogen activator in response to trauma 
or blood stasis. Exogenous and endogenous coagulation 
pathways are depended on the direct contact of coagu-
lation factors with the endothelial cells (Pettigrew 2001; 
Geenen et al. 2012).
Hence thrombogenesis is a composite of mechani-
cal and chemical interactions involving neurons, the 
endothelium and components of vasomotion. Τhe 4th 
factor could be implicated in more than one processes 
required for thrombus formation and stabilization.
In terms to stimulation parameter to be used for VTE 
prophylaxis, the pool of evidence does not demonstrate 
any particular pattern providing superiority. After exten-
sive literature review, no comparisons between differ-
ent current characteristics were found in terms of VTE 
prophylactic efficacy. Extrapolating parameter-related 
conclusions from other applications of EMS (such as, 
for ICU-acquired weakness) does not appear appropri-
ate, since there is no suggested identical mechanism of 
action with VTE prophylaxis. Furthermore, the fact that 
quite different parameters appeared effective across dif-
ferent settings and studies (Table  1), as well as the fact 
that hemodynamic parameters correlate poorly with VTE 
prophylactic effects (Morris and Woodcock 2004) may 
indicate that, what mostly matters is the duration of the 
application over the 24  h period. Thus, pending further 
evidence, it appears reasonable to select a current inten-
sity (dose) causing brisk contractions, if possible, but 
certainly be comfortable enough to allow application for 
most hours per day, during the entire period in which the 
patient is at moderate or severe risk of VTE. Any sugges-
tion of other parameters (frequency, pulse shape, pulse 
duration, on: off time, ramp up/down etc.) has not been 
investigated sufficiently, hence, any suggestion is much 
likely to be proven false.
Further vascular benefits; and hurdles related to the EMS
The present review focuses on the beneficial effects of 
the EMS on the veins. Further to that, there is strong 
evidence that the beneficial effects of the application are 
more global, involving all vessels via additional mecha-
nisms, likely most importantly those inducing mobi-
lization of endothelial progenitor cells from the bone 
marrow (Stefanou et al. 2016). The latter are considered 
to exert healing effects on the injured endothelium by the 
insults of illness. This regeneration potential may be of 
vital clinical importance (Balistreri et al. 2015).
Probably the most bothersome and discussed prob-
lem related to the EMS is tolerance—namely fatigue and 
pain. A systematic review on its use for thomboprophy-
laxis, which included 21 studies, concluded that, in ref-
erence to modern devices, EMS is generally associated 
with an acceptable tolerability, potentially leading to 
good patient compliance. Newer EMS methods do not 
induce painful contractions as the case had been with 
the devices used intraoperatively during the 80s and 
90s (requiring general anesthesia); and may be applied 
multiple times daily; yet this requires further evaluation 
(Hajibandeh et al. 2015).
In the context of application of bundles of measures 
with pleotropic effects in the ICU, step-down unit and 
rehabilitation, EMS arises as a potent advantageous 
Table 1 Parameters of EMS aiming to provide VTE prophylaxis, used across different studies, where reported
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modality in multiple levels. It has shown to exert ben-
eficial metabolic effects (Hamzaid and Davis 2009); and 
likely contributes to the prophylaxis from ICU-acquired 
weakness (Gorgey et  al. 2012) and associated earlier 
weaning from the ventilator (Routsi et al. 2010); the heal-
ing of deep tissue injury (Franek et  al. 2012); the post-
injury nerve regeneration (Xu et  al. 2014); it improves 
endothelial function (as demonstrated by the flow-
depended brachial artery dilatation); and exerts anti-
inflammatory effects (as demonstrated by TNF-alpha, 
s-ICAM-1, s-VCAM-1 and TNF-α/IL-10 ratio reduction) 
(Karavidas et al. 2006).
Conclusion
Evidence supports the hypothesis that, neural supply to 
the veins provides direct antithrombic effects, a factor 
not included in Virchow’s triad. EMS appears to be one 
mechanism that, via neurogenic pathways, influences this 
4th factor, thus suppressing thrombogenesis. As VTE 
remains one of the most preventable causes of in-hospital 
mortality, this hypothesis and factor as well as ways to 
affect it need to be explored. In addition, EMS needs to 
be investigated with well-designed RCTs for its possible 
additive effect on each thromboprophylactic measure, 
including the mechanical ones, as its implementation 
may save numerous lives.
Implication
By ‘replacing’ the lost periodic neural supply to the veins, 
or by enhancing so, EMS acts not only by blood veloc-
ity modifications (as part of the Virchow’s triad) but also 
by the 4th factor. Although EMS might have a secondary 
role in thomboprophylaxis, the prevalence and mortal-
ity of VTE are so high that it may save a great number of 
lives; and since it may target a unique aspect of the dis-
ease pathogenesis, its role perhaps will not be substituted 
by alternative mechanical measures; but it may be applied 
in combination with the latter, providing additive effects. 
Further to that, the most important implication of iden-
tifying and exploring the related pathophysiology of the 
4th factor as part of thrombus pathogenesis is that, after 
scrutiny to fully characterize, quantify, and modify, with 
research focused on specific questions, new thrombopro-
phylactic strategies (in addition to EMS) may be found 
based on this factor; and applied to patients under condi-
tions in which the 4th factor is affected or when the risk of 
VTE is high, such as, after major operations, trauma, or in 
ICU patients.
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